Trial characteristics
Summary table
| Trial characteristics | Results |
|---|---|
| Design | - |
| Pilot trial | 58 of 396 (14.6%) |
| Medication intervention | 228 of 396 (57.6%) |
| Blinding reported | 199 of 396 (50.3%) |
| High risk of bias | 186 of 396 (47.0%) |
| Centres | - |
| Multicentred | 75 of 396 (18.9%) |
| Number of centres in multicentred | 5 (2, 14.5) min=2 max=104 n=75 |
| Countries | - |
| Multinational | 28 of 396 (7.1%) |
| International collaboration | 65 of 396 (16.4%) |
| Funding | - |
| Any funding reported | 194 of 396 (49.0%) |
| Any commercial funding reported | 46 of 396 (11.6%) |
| Results | - |
| Total children randomized | 4.7410^{4} |
| Children randomized per RCT | 52.5 (34, 100.2) min=6 max=4947 n=396 |
| Children analyzed | 50 (32, 97.5) min=6 max=4947 n=378 |
| Stopped early | 54 of 204 (26.5%) |
| Results statistically significant | 96 of 240 (40.0%) |
| Trial characteristics | Results |
|---|---|
| Impact | - |
| Journal impact factor | 3.6 (2.3, 6.3) min=0.4 max=55.9 n=318 |
| Citations per year | 1.7 (0.7, 3.3) min=0 max=37.5 n=289 |
Figures
Children randomized per RCT
Interventions tested
Indication for interventions tested
Population studied
